EOLS FY 2018 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$9,000

Operating Income

-$46M

Net Income

-$47M

EPS (Diluted)

$-1.92

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$172M

Total Liabilities

$87M

Stockholders' Equity

-$123M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$9,000	-$218,000	+95.9%
Operating Income	-$46M	-$12M	-293.5%
Net Income	-$47M	-$4M	-946.1%